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Screening for congenital heart malformation
in child health centres
Rikard E Juttmann,a John Hess, Caspar WN Looman,a Gerrit J van Oortmarssena and
Paul J van der Maasa
Background Although screening for congenital heart malformations is part of the child health
care programme in several countries, there are very few published evaluations of
these activities. This report is concerned with the evaluation of this screening at
the Dutch Child Health Centres (CHC).
Methods All consecutive patients, aged between 32 days and 4 years, presented at the
Sophia Children's Hospital Rotterdam throughout a period of 2 years, with a con-
genital heart malformation were included in this study. Paediatric cardiologists
established whether or not these patients were diagnosed after haemodynamic
complications had already developed (diagnosed 'too late'). Parents and CHC-
physicians were interviewed in order to establish the screening and detection
history. Test properties were established for all patients with a congenital heart
malformation (n = 290), intended effects of screening were established in patients
with clinically significant malformations (n = 82).
Results The sensitivity of the actual screening programme was 0.57 (95% CI: 0.51-0.62),
the specificity 0.985 (95% CI: 0.981-0.990) and the predictive value of a positive
test result 0.13 (95% CI: 0.10-0.19). Sensitivity in a subpopulation of patients
adequately screened was 0.89 (95% CI: 0.74-0.96). Adequately screened pa-
tients were less likely to be diagnosed 'too late' than inadequately screened patients
(odds ratio [OR] = 0.20, 95% CI: 0.04-1.05). The actual risk of being diagnosed
'too late' in the study-population (48%) was only slightly less than the estimated
risk for patients not exposed to CHC-screening (58%, 95% CI:43%-72%).
Adequately screened patients however were at considerably less risk (17%, 95%
CI : 4%-48%).
Conclusion Screening for congenital heart malformations in CHC contributes to the timely
detection of these disorders. The actual yield, however, is far from optimal, and
the screening programme should be improved.
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In several countries, periodic health examinations are part of
the preventive child health care programme.1"5 In the Nether-
lands, this programme is executed at the Child Health Centres
(CHC). These examinations generally include routine medical
check-ups of heart and circulation, and are aimed at the early
detection of congenital heart malformations. However, there
are no published examples of these screening activities.2'6
Screening evaluation aims at establishing both favourable
and unfavourable effects of screening. Unfavourable effects are
mainly due to false-negative and false-positive test results,
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the numbers of which are determined by the test properties.
Favourable effects are defined as the reduction of adverse out-
comes of diseases as a result of early detection and subsequent
intervention.7
Approximately half of all cases of congenital heart disease
are detected soon after birth by neonatal examinations or due
to the onset of symptoms. The remaining patients initially go
unrecognized.8 Child Health Centre screening is merely aimed
at the latter; the first examination is scheduled at the age of one
month.
Since many of these disorders spontaneously resolve and
have no haemodynamic impact in the short or long run,
the intended effects of screening will only occur in clinically
significant congenital heart malformations, which give rise to
progressive disease.
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The adverse outcomes to be prevented are haemodynamic
complications, notably heart failure and hypoxaemia. Disorders
should be detected 'in time', i.e. before these complications occur.
Children who have already developed haemodynamic compli-
cations at the first cardiological consultation, have been diagnosed
'too late', even if these complications are still reversible by
therapy. Since haemodynamic complications can be prevented
with the help of modem interventionaJ paediatric cardiology10'1'
and cardiac surgery,12"16 in most patients who are diagnosed
'in time', reducing the number of patients diagnosed 'too late'
may be considered the target of the screening programme.
Compared to patients with moderate disorders, patients with
severe disorders may be more at risk for developing com-
plications. These patients are also less likely to have undergone
screening prior to the development of complications due to
rapid deterioration. In an observational evaluation of screening
this may give rise to length bias, leading to an overestimation of
the favourable effects of screening. This requires adjustment for
confounding.17
Official guidelines for screening at the Dutch CHC regarding
procedures and ages of investigation are defined by the Dutch
1 ft
National Association for Home Care. There is, however, a
substantial variation in the actual performance.19
The purpose of this paper is: (1) To estimate the test prop-
erties of the CHC screening programme for congenital heart
malformations, as actually performed in the south-west of the
Netherlands, and the maximum attainable sensitivity were all
patients to be adequately screened according to the guidelines.
(2) To estimate the effect of the present screening programme
on the proportion of patients with clinically significant
malformations arriving 'too late' in a paediatric cardiology
department, and the potential effect were all patients to be
adequately screened, according to the guidelines.
(3) To inventory the actual deviations from the guidelines in
the present screening programme.
Methods
Study group
AH patients who fulfilled the following conditions were included
in this study: First cardiological consultation at the Sophia
Children's Hospital took place between 11 April 1994 and 11
April 1996; children were aged between 32 days and 4 years;
children presented for the first time with a congenital anatomical
heart malformation; children were resident in the south-west of
the Netherlands, more specifically the area from which, by
national agreement between paediatric centres, all children with
cardiovascular disorders are referred to the Sophia Children's
Hospital.
Parents were informed and consented to their children's par-
ticipation in the study and so the study group thus comprised
290 patients (Table 1).
The intended effects of screening can only be established in
patients with clinically significant congenital heart malforma-
tions. A malformation was defined as clinically significant when
it was decided to perform a therapeutic intervention within
9 months after the first cardiological consultation. Eighty-three
patients satisfied this condition, of whom 82 were included in
the analysis (Table 1).
Table 1 Patients aged between 32 days and 4 years, who were first seen at the Sophia Children's Hospital, Department of Paediatric Cardiology
between 10 April 1994 and 10 April 1996
Parents did not consent to
data collection for the study: 5
1142(
Parents consented to
data collection: 1137
no congenital anatomical
heart malformation: 847:
• dysrhythmla: 25
• Kawasaki's disease: 20
• disorders of pericardium
and myocardium: 12
• secondary hypertrophy
of right ventricle: 6
• innocent murmur: 386
• normal heart: 398
no clinically significant '
disorder: 207
congenital anatomical heart *
malformation: 290
clinically significant
disorder: 83
screening data not
. available: 17
screening data
available: 190
screening data not
available: 1
screening data
available: 82
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Data collection and definition of variables
To establish whether patients were diagnosed 'too late' or 'in
time' a questionnaire was filled in by the paediarric cardiologist
in charge at the first cardiological consultation. The following
aspects were examined: extent of heart failure, resulting from
pressure- or volume-load (none, moderate, serious, very serious);
degree of hypoxaemia (none, moderate, serious, very serious);
risk of deterioration; estimated duration of symptoms. Another
paediatric cardiologist was asked to give a second opinion by
filling in an identical questionnaire independently. In the event
of differences between the answers of the two physicians, a
third colleague was asked to make the final judgement.
Diagnosis was considered to have been established too late if:
heart failure or hypoxaemia was classified as serious or very
serious; heart failure or hypoxaemia was classified as moderate,
the risk for deterioration was considered realistic and the symp-
toms were estimated to have existed for over one month. All
other disorders were considered to have been diagnosed in time.
To make it possible to adjust for length bias paediatric cardio-
logists were also asked to appraise the severity of the disorder by
opting for one of four qualifications: trivial, moderate, severe,
and very severe.
In order to establish whether or not their child's disorder was
detected as a result of the CHC screening programme, parents
were interviewed by a nurse at the first cardiological consulta-
tion. If necessary, additional information was collected from
CHC physicians, general practitioners and clinical specialists.
Disorders were assumed to have been detected by the physician
who was the first to initiate a referral for a cardiovascular dis-
order. Patients were classified as having been detected by a CHC
physician or not.
In order to establish the screening history, the CHC physicians
of all patients were approached for an interview. The first author,
who was not informed about the nature and severity of the
disorder, performed all interviews. Questions were asked about
the doctor's normal screening routine and about the actual pro-
cedure in this particular case.
A screening history was classified as 'adequate' if: until
the first cardiological consultation the CHC was visited at least
according to the standard visit schedule, which entails: one visit
before the age of 35 days, one in the age interval between 35
and 95 days (first DPTP-Hib-vaccination), one in the age interval
between 3 and 14 months (MMR-vaccination) and subsequently
one visit every year until the age of 4, and during all these visits
the CHC physician performed at least auscultation of the thorax,
judged skin colour, size of the liver and weight gain and asked
questions aimed at assessing the child's exercise tolerance, and
the child was referred as soon as one of the following symptoms
was found: heart murmur classified by the CHC physidan as
suspect; central cyanosis; enlarged liver; combination of heart
murmur classified by the CHC physidan as non-suspect and
weight gain dassified by the CHC-physidan as insuffident;
combination of heart murmur dassified by the CHC physidan
as non-suspect and anamnestic dues for exercise intolerance-
combination of weight gain dassified by the CHC physidan as
insuffident and anamnestic dues for exercise intolerance.
Screening history was either classified as adequate or as in-
adequate. For 'inadequate' screened patients the reasons for this
dassifications were spedfied.
To determine screening test properties additional data were
collected: all referrals for congenital heart malformation by
Rotterdam CHC physidans were registered during the second
half of 1996; figures on births in Rotterdam and the south-west
of the Netherlands induding Rotterdam were acquired from
Statistics Netherlands.
Analysis
It is our opinion that it is essential for patients, parents and their
physidans to be informed of any congenital heart malformation
present, even if the disorder should eventually prove to have no
haemodynamic consequences. Therefore test properties were
established for all 290 patients with a congenital heart mal-
formation. To establish the intended effects of screening, how-
ever, the analysis was restricted to the 82 patients with clinically
significant disorders.
With regard to the latter, logistic regression was used to derive
odds ratios (OR), induding 95% confidence intervals (CI), for
being diagnosed too late depending on whether or not being
screened adequately and on whether or not being detected by
CHC screening. In both analyses, correction for severity was
applied in order to adjust for length bias.
To appredate the effects of screening the proportions of patients
diagnosed too late and in time in an imaginary population
not exposed to screening are estimated. We assume that these
proportions will be appropriately estimated by the proportions
'too late' and 'in time' among patients with clinically significant
disorders, who were not detected by a CHC physidan, corrected
for severity (in this imaginary population a distribution of
severity similar to the complete study group may be expected).
This estimate was compared to the proportions of diagnoses
made too late and in time in the complete study population (i.e.
exposed to screening as it was actually performed) and in the
sub-population with an adequate screening history (proportions
in this sub-population (n = 12) could not be corrected for
severity, since numbers of patients were too small).
Results
Patient inclusion
As shown in Table 1, of all 1142 patients aged between 32 days
and 4 years, who were examined during the study by a
paediatric cardiologist in the Sophia Children's Hospital for the
first time, 290 appeared to have a congenital heart malforma-
tion. The screening history of 272 of these patients could be
documented. Eighty-three patients were eventually diagnosed
as having a clinically significant disorder, of whom in 82 the
screening history could be collected. The findings of the
two paediatric cardiologists were identical in 79 cases. A third
opinion was necessary in three cases. Forty-nine patients (60%)
suffered from large left-to-right shunts. Cyanotic heart disease
was found in 15 patients (18%) and disorders resulting in
increased pressure-load were seen in seven patients (9%). The
remaining 11 patients (13%) had miscellaneous malformations.
Test properties
Of 290 patients 164, had been detected by a CHC physidan. In
36 (out of 272) patients all requirements for adequate screen-
ing had been met. Thirty-two of these were detected by a
CHC physidan. The number of referrals for congenital heart
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Table 2 Calculation of incidence of cases of congenital heart
malformation (CHM) diagnosed between 32 days and 4 years, the test
properties of the actual CHC screening activities during 2 years in the
south-west of the Netherlands and the sensitivity of this screening in a
subset of adequately screened patients. (Numbers in parentheses
indicate adequately screened patients)
Screening
+
-
Total
CHM
+
164(32)
126(4)
290 (36)
-
1083
74 068
75 151
Total
1247
74 194
75 441
Incidence 290/75 441 -
Sensitivity: 164/290 =
Spedficlty 74 068/75 151
Predictive value 164/1247 =
positive test.
Sensiuvity if adequately 32/36 -
screened:
3 8 per 1000 children
0 57(95%CI 0.51-0 62)
0 985 (95% CI . 0 981-0 990)
0 13(95% CI. 0.10-0.19)
0.89 (95% CI • 0 74-0.96)
Table 3 Classification of the 82 patients with clinically significant
disorders diagnosed too late' and 'in rime' in categories 'adequately
screened' and 'inadequately screened', and 'detected by Child Health
Centres [CHC]' and 'not detected by CHC
Adequately screened
Inadequately screened
Total
Detected by CHC
Not detected by CHC
Total
Too late
2 (17%)
37 (53%)
39 (48%)
16(36%)
23 (62%)
39 (48%)
In time
10 (83%)
33 (47%)
43 (52%)
29 (64%)
14(38%)
43 (52%)
Total
12 (100%)
70(100%)
82 (100%)
45 (100%)
37(100%)
82 (100%)
Odds Ratios: for being too late' depending on whether or not adequately
screened.
= 0.18, 95% CI: 0.04-0.87
= 0.20, 95% CI: 0.04-1.05 corrected for severity.
for being too late' depending on whether or not detected by CHC screening
= 0.34, 95% CI : 0.14-0.83
= 0.39, 95% CI 0.15-1 00 corrected for severity
malformation by Rotterdam CHC physicians in 6 months was
60. The numbers of births in the south-west of the Netherlands
and Rotterdam during 1994-1995 were 75 441 and 14 524 re-
spectively. Hence the number of CHC referrals throughout a period
of 2 years in the area under discussion is estimated as 75 441/14
524 x 4 x 60 = 1247. On the basis of these figures, test properties
are calculated and subsequently presented in Table 2. The sen-
sitivity of the actual screening programme was 0.57, the speci-
ficity 0.985 and the predictive value of a positive test result 0.13.
Sensitivity in the adequately screened sub-population was 0.89.
These data also allow calculation of the incidence rate of con-
genital heart malformations in children aged from one month
until 4 years: 0.38%.
Effectiveness
For the 82 patients with a clinically significant disorder, dis-
tributions of screening and detection history in relation to the
outcome measures (diagnosed 'too late'/'in time') are shown in
Table 3. Of these 82 patients, not surprisingly none was qualified
as having a trivial disorder. Twenty-nine (35%) of these patients
proved to have a moderate, 40 (49%) a severe and 13 (16%) a
very severe disorder. Table 3 shows that adequately screened
children were less likely to be diagnosed too late than in-
adequately screened ones. This was also the case for patients
detected by CHC physicians compared to patients detected other-
wise. After correction for severity, both OR hardly increased,
although both CI now just include 1.00.
In an imaginary population not exposed to CHC screening,
the estimated percentage of children diagnosed too late and in
time, based on proportions among children not detected by
CHC physicians after correction for severity, are 58% and 42%
respectively.
As summarized in Table 4, the risk of being diagnosed too late
in a population exposed to CHC screening as actually performed
in the present study population, is not much lower than
the estimated risk for patients in a population not exposed to
CHC screening. In an adequately screened population, however,
patients would probably be at considerably less risk of being
diagnosed too late.
Inventory of deviations from guidelines
Only 12 patients with clinically significant disorders (15%)
qualified as having been screened adequately according to the
guidelines (Table 5). Four children (5%) visited the CHC at
recommended ages and were correctly screened by the CHC
physician, but were not referred in spite of a positive test. The
other children were either not screened at recommended ages
(10; 12%), or not correctly screened by the CHC physician (22;
27%) or both (34; 41%); including the seven children who
never have visited the CHC.
Discussion
The incidence of congenital heart malformations in the Nether-
lands is estimated at 0.8%.9 Half of these cases are likely to be
diagnosed before the age of one month.8 These data coincide with
the incidence rate of 0.38% for congenital heart malformations
in children aged from one month until 4 years found in this
study.
Considering Table 2, we estimate that under the actual screen-
ing regime in the south-west of the Netherlands, over a period
of 2 years, 126 patients with a congenital heart malformation
will not be detected by CHC physicians but by others (false-
negatives). Overall 1082 children will be referred for a con-
genital heart malformation by CHC physicians, although further
clinical assessment will fail to reveal such disorders (false-
positives). If all children were screened adequately, it is estimated
that the number of false-negatives would be reduced to (4/36)
x 290 = 32. Whether such an improvement will change the
false-positive rate is difficult to predict and no estimates can be
based on the present data. Distress caused by false-positive test
results is generally considered to be less severe than distress and
adverse health effects caused by false-negative test results.7 For
this reason and in the light of the substantial reduction in
numbers of false-negatives, a considerable increase in the num-
ber of false-positives would be required to neutralize the positive
effects of such a change in policy. If for example the relation
between the harm caused by false-negative and false-positive
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Table 4 Proportions of patients diagnosed 'too late' and 'in time' in populations subjected to different screening expositions
Too late In time
Imaginary population not exposed to CHC screening
Population exposed to CHC screening as actually performed
Population exposed to adequate screening
58% (95% CI : 43-72)
48%
17% (95% CI •
42% (95% CI : 28-57)
52%
83% (95% CI : 52-95)
Table 5 Causes of deviation from guidelines for screening procedures
Screening history
Adequately screened
Screening at recommended ages, correctly performed and referred in case of a positive test result 12 (15%)
Inadequately screened
Screening at recommended ages, correctly performed but not referred in spite of a positive test result 4 (5%)
Screening not at recommended ages, though correctly performed 10 (12%)
Screening at recommended ages, but not correctly performed 22 (27%)
Screening both not at recommended ages and not correctly performed 34 (41%)
Total 82 (100%)
test results is expressed as a ratio of 10:1, the number of false-
positives will almost have to be doubled to 1082 + (126-32) x
10 = 2022 to neutralize the effect of the reduction of false-
negatives.
From a methodological point of view the most appropriate
design for evaluating potential benefits of screening is a
randomized controlled trial (RCT). Should practical and ethical
grounds render a RCT infeasible for evaluating a screening pro-
gramme, which is already established and running, observational
designs must be resorted to, meticulously considering possible
sources of confounding.7
A patient follow-up design is used in our study, in which the
determinants (screening and detection history) are established
retrospectively and the outcome measure (in time/too late)
prospectively. In order to use this design, it is essential that
treatment for the disorder under discussion can be safely post-
poned until the disease has progressed up to a stage in which
spontaneous resolution can no longer be expected. Con-
sequently, overestimation of the positive effects of screening as
result of overtreatment of regressive disorders can be avoided.
The management approach in modern paediatric cardiology is
cautiously expectant. The decision to treat is always postponed
until haemodynamic complications are judged to be inevitable
in the short or longer run. Given the nature of the disorders
under discussion—relatively large anatomical defects—and
the extensive research data on the natural history, paediatric
cardiologists may be assumed to be reliable in their prognosis of
the natural course.20"23
The differences between adequately and inadequately screened
patients may partly be induced by selection bias. If we presume
that after correction for severity this bias will be of little con-
sequence, we may conclude that adequately screened children
are better off than those inadequately screened and that in-
creasing the proportion of adequately screened children will
reduce the incidence of haemodynamic complications from
congenital heart malformations. Inadequate screening is a
result of both insufficient attendance by parents and incorrect
performance by CHC physicians. We are convinced that both
aspects can be improved by health education and management
provisions.
Conclusion
The present study indicates that systematic screening for con-
genital heart malformation in CHC in the Netherlands contributes
to the timely detection and treatment of these disorders. The
actual yield of the programme, however, is far from optimal,
and screening attendance and performance should be improved.
Optimization of screening participation and performance may
improve screening considerably, resulting in timely treatment of
most patients.
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